The Food and Drug Administration on Wednesday approved the sale of an antibiotic for the treatment of urinary tract infections in women, giving U.S. health providers a powerful new tool to combat a common infection that is increasingly unresponsive to the existing suite of antimicrobial drugs.
The drug will be marketed in the U.S. as Pivya and will be made available by prescription to women 18 and older.
It is the first time in two decades that the F.D.A.
has approved a new antibiotic for U.T.I.s, which annually affect 30 million Americans.
is committed to fostering new antibiotic availability when they prove to be safe and effective.”
Persons:
U.T.I.s, Dr, Peter Kim
Organizations:
Drug Administration, Drug, Research
Locations:
Europe, U.S